Tecovirimat as treatment for patients hospitalised due to monkeypox virus infection

Document first published:
Page updated:
Topic:
Publication type:

Document

Clinical Commissioning Rapid Policy Statement: Tecovirimat as treatment for patients hospitalised due to monkeypox virus infection

Clinical Commissioning Rapid Policy Statement: Tecovirimat as treatment for patients hospitalised due to monkeypox virus infection

  • PDF
  • 211 KB
  • 5 pages

Summary

This rapid policy statement outlines the eligibility criteria for the use of tecovirimat in the treatment of hospitalised patients with monkeypox virus infection.

Published: 20 September 2022